Research Progress of Lidocaine Transdermal Preparations

doi:10.3969/j.issn.2095-1396.2020.03.003

Abstract

Abstract:

Objective：To explore the research progress of lidocaine transdermal preparations and provide references for the preparation of new，safe and efficient transdermallocal anesthetic preparations required for clinical treatment. Methods：The relevant literatures

of lidocaine transdermal preparations at home and abroad were searched in recent years，and the main dosage forms and characteristics of the transdermal preparations were reviewed. Results： Lidocaine transdermal preparations can increase the transdermal rate，have a rapid onset of action，improve bioavailability，and reduce adverse reactions. The currently retrieved lidocaine dosage forms include creams，gels and other traditional preparations and microemulsions，microemulsion gels，liposomes，alcohol liposomes，film sprays，cataplasms，mesoporous silica nanoparticles. The particles are loaded with new carrier dosage forms such as lidocaine. Conclusion：With the development of new transdermal dosage forms and new technologies， the research results of lidocaine transdermal preparations are expected to be used safely and efficiently in the future.

Key words: lidocaine, transdermal preparation, research progress

CLC Number:

R944

JIN Shan, ZHANG Dan-shen. Research Progress of Lidocaine Transdermal Preparations[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(3): 16-20.

References

[1] 刘婷婷. 盐酸利多卡因巴布剂的研制及药动学研究[D]. 武汉: 华中科技大学, 2007.

[2] 梁佳敏, 李楠, 徐海蓉, 等. 经皮给药系统的体外释放、透皮特性及体内药动学研究进展[J]. 武警后勤学院学报：医学版, 2013, 22(12): 1137-1140.

[3] 王雪艳, 黄艳萍, 杨莹, 等. 两种促渗方式对虫草素的透皮影响的实验研究[J]. 中国医疗美容, 2018, 8(09): 84-87.

[4] 谢明华. 利多卡因微乳凝胶外用制剂的制备及药效学评价[D]. 杭州:浙江大学, 2014.

[5] 杨永鹏, 朱晓亮, 董萍, 等. 高效药用透皮载体-纳米乳及其低碳制备技术用于医学美容及皮肤抗衰老高端新型系列化妆品领域之一: Qipa医学美容专用经皮快速高效麻醉镇痛纳米乳[J]. 中国化妆品(行业), 2010(09): 69-76.

[6] 贺亚静, 武学鑫, 周洁, 等. 复方利多卡因乳膏体外透皮研究[J]. 中国药业, 2015, 24(15): 19-21.

[7] 舒成仁, 葛苗苗, 黄露, 等. 复方利多卡因乳膏体外透皮吸收实验[J]. 医药导报, 2011, 30(08): 997-999.

[8] Harneet Marwah, Tarun Garg, Amit K Goyal, et al. Permeation enhancer strategies in transdermal drug delivery[J]. Drug Delivery, 2014, 23(2): 1-15.

[9] 罗斌华, 丁洁琼, 曹畏. 利多卡因微乳的制备及性质考察[J]. 山西医药杂志, 2013, 42(09): 1060-1061.

[10] 季新燕, 杨李旺, 冯前进, 等. 利多卡因微乳制备及体外透皮吸收研究[J]. 世界中西医结合杂志, 2013, 8(04): 407-409, 429.

[11] Zhao Ze-yu, Lian Yu-fei, Zhu Yu-hui, et al. Depot lidocaine-loaded microemulsion for prolonged local anesthesia: Different efficacy model studies[J]. Elsevier, 2020, 55(C).

[12] Maulvi Furqan A, Pillai Lakshmi V, Patel Kajal P, et al. Lidocaine tripotassium phosphate complex laden microemulsion for prolonged local anaesthesia: In vitro and in vivo studies[J]. Pubmed, 2020, 185: 110632.

[13] 李欣, 刘华. 利多卡因凝胶在手术治疗麦粒肿中的应用及效果观察[J]. 护士进修杂志, 2019, 34(13): 1214-1215.

[14] Yeon Jin Jeong, Ho Jun Kim, Hyung-sup Kwon, et al. The use of topical lidocaine gel during intermaxillary fixation procedure[J]. J Craniofacial Surgery, 2016, 27(5): 1.

[15] Antonio Bardocci, Giorgio Lofoco, Serenella Perdicaro, et al. Lidocaine 2% gel versus lidocaine 4% unpreserved drops for topical anesthesia in cataract surgery: A randomized controlled trial[J]. Ophthalmology, 2003, 110(1): 0-149.

[16] Parr A M, Zoutman D E, Davidson J S D. Antimicrobial activity of lidocaine against bacteria associated with nosocomial wound infection[J]. Annals of Plastic Surgery, 1999, 43(3): 239-245.

[17] 葛敏, 彭佳蓓, 乐加薇, 等. 利多卡因微乳凝胶剂的制备及体外透皮特性[J].中国临床药学杂志, 2015, 24(06): 339-342.

[18] 谢明华, 蔡鑫君, 封玲, 等. 利多卡因微乳凝胶剂的制备及初步药效学研究[J]. 中国现代应用药学, 2015, 32(04): 442-446.

[19] 俞振伟, 梁漪, 梁文权. 雌二醇透皮喷雾成膜剂的研制及其体外评价[J]. 药学学报, 2013, 48(05): 746-751.

[20] 王超君, 谷娜, 孙义峰, 等. 创面用复方喷雾膜剂的制备及其性质研究[J]. 东南国防医药, 2013, 15(06): 577-580.

[21] 崔曰新. 盐酸利多卡因喷膜剂的制备[D]. 广州: 广东药科大学, 2016.

[22] 冷福建. 利多卡因固体脂质纳米粒的研究[D]. 武汉: 华中科技大学, 2012.

[23] Leng Fu-jian, Wan Jiang-ling, Liu Wei, et al. Prolongation of epidural analgesia using solid lipid nanoparticles as drug carrier for lidocaine[J]. Regional Anesthesia & Pain Medicine, 2012, 37(2): 159-165.

[24] Touitou E, Dayan N, Bergelson L, et al. Ethosomes - Novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties[J]. J Controlled Release, 2000, 65(3): 403-418.

[25] 李富利. 新型经皮局麻药物制剂—利多卡因醇质体的研究[D]. 广州: 南方医科大学, 2011.

[26] Ralf Baron, Victor Mayoral Rojals, Goran Leijon, et al. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study[J]. Current Medical Research & Opinion, 2009, 25(7): 1663-1676.

[27] 沈晨, 王强, 王东凯. 利多卡因巴布剂体外透皮吸收研究[J]. 广东化工, 2018, 45(16): 15-16.

[28] 师有栋, 孙杰. 复方乳没利多卡因缓释贴膜的制剂工艺研究[J]. 卫生职业教育, 2014, 32(22): 91-92.

[29] Shohreh Nafisi, Naghmeh Samadi, Mahboubeh Houshiar, et al. Mesoporous silica nanoparticles for enhanced lidocaine skin delivery[J]. International J Pharmaceutics, 2018, 550(1-2):325-332.

[30] 吴杰, 赖跃兴, 吴梅, 等. 健康教育加辅助措施提高上消化道内镜检查黏膜清晰度的临床观察[J]. 临床荟萃, 2020, 35(05): 434-437.

[31] 刘春妹. 氯胺酮与异丙酚复合利多卡因在小儿手术麻醉中的应用效果[J]. 临床合理用药杂志, 2020, 13(12): 105-106.

[32] 刘沛燕. 带状疱疹后神经痛治疗研究进展[J]. 中医临床研究, 2019, 11(29): 121-125.